188 related articles for article (PubMed ID: 33432333)
1. Anthracyclines and regional myocardial damage in breast cancer patients. A multicentre study from the Working Group on Drug Cardiotoxicity and Cardioprotection, Italian Society of Cardiology (SIC).
Zito C; Manganaro R; Cusmà Piccione M; Madonna R; Monte I; Novo G; Mercurio V; Longobardo L; Cadeddu Dessalvi C; Deidda M; Pagliaro P; Spallarossa P; Costantino R; Santarpia M; Altavilla G; Carerj S; Tocchetti CG
Eur Heart J Cardiovasc Imaging; 2021 Mar; 22(4):406-415. PubMed ID: 33432333
[TBL] [Abstract][Full Text] [Related]
2. Effects of exercise training on cardiac toxicity markers in women with breast cancer undergoing chemotherapy with anthracyclines: a randomized controlled trial.
Antunes P; Joaquim A; Sampaio F; Nunes C; Ascensão A; Vilela E; Teixeira M; Capela A; Amarelo A; Marques C; Viamonte S; Alves A; Esteves D
Eur J Prev Cardiol; 2023 Jul; 30(9):844-855. PubMed ID: 36857149
[TBL] [Abstract][Full Text] [Related]
3. The Predictive Value of 2D Myocardial Strain for Epirubicin-Induced Cardiotoxicity.
Ben Abdallah I; Ben Nasr S; Chourabi C; Boukhris M; Ben Abdallah I; Zribi A; Fendri S; Balti M; Fehri W; Chraiet N; Haddaoui A
J Oncol; 2020; 2020():5706561. PubMed ID: 33335549
[TBL] [Abstract][Full Text] [Related]
4. Superiority of left heart deformation in early anthracycline-related cardiac dysfunction detection.
Giang M N; Nguyen H H; Vo DT; Ho Huynh Quang T; Phan DTH; Chau NH
Open Heart; 2023 Nov; 10(2):. PubMed ID: 38011990
[TBL] [Abstract][Full Text] [Related]
5. Left ventricular segmental strain and the prediction of cancer therapy-related cardiac dysfunction.
Demissei BG; Fan Y; Qian Y; Cheng HG; Smith AM; Shimamoto K; Vedage N; Narayan HK; Scherrer-Crosbie M; Davatzikos C; Ky B
Eur Heart J Cardiovasc Imaging; 2021 Mar; 22(4):418-426. PubMed ID: 33206976
[TBL] [Abstract][Full Text] [Related]
6. Serial Cardiac MRI for Quantification of the Dynamics of Anthracycline-Induced Subclinical Myocardial Injury.
Zheng Y; Liu H; Zhao L; Guan S; Huo H; Li H; Guo J; Peng X; Hao Y; Jin S; Hou Y; Dai X; Liu T; Zhang X
J Magn Reson Imaging; 2023 Nov; 58(5):1533-1541. PubMed ID: 36912379
[TBL] [Abstract][Full Text] [Related]
7. Echocardiographic predictors of symptomatic cardiotoxicity among patients undergoing chemotherapy: A systematic review and meta-analysis.
Siddiqui MU; Yaacoub Y; Hanson HA; Junarta J; Pasha AK; Shah M
Medicine (Baltimore); 2022 Jul; 101(28):e29562. PubMed ID: 35839035
[TBL] [Abstract][Full Text] [Related]
8. Intrinsic Wave Velocity Propagation: A Novel Parameter for Assessing the Effect of Anthracycline Chemotherapy Agents on Cardiac Diastolic Function in Breast Cancer Patients.
Huang X; Fan XY; Cheng Q; Zhang J; Sun J; Tang QY; Deng YB; Bi XJ
Curr Med Sci; 2023 Dec; 43(6):1229-1237. PubMed ID: 38041790
[TBL] [Abstract][Full Text] [Related]
9. Study of stress-strain loops on cardiotoxicity related to immune checkpoint inhibitors.
Chunlan S; Bing Y; Xi W
Echocardiography; 2024 Jan; 41(1):e15746. PubMed ID: 38284683
[TBL] [Abstract][Full Text] [Related]
10. Association between baseline hemodynamic indices, cardiotoxicity risk, and survival in women with breast cancer.
Decorads CE; Lambert A; Roch V; Imbert L; Perrin M; Claudin M; Doyen M; Citerne Q; Lamiral Z; Peiffert D; Henneton C; Marie PY
J Nucl Cardiol; 2024 May; 35():101849. PubMed ID: 38508443
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy-related cardiac dysfunction: the usefulness of myocardial work indices.
Di Lisi D; Manno G; Madaudo C; Filorizzo C; Intravaia RCM; Galassi AR; Incorvaia L; Russo A; Novo G
Int J Cardiovasc Imaging; 2023 Oct; 39(10):1845-1853. PubMed ID: 37548845
[TBL] [Abstract][Full Text] [Related]
12. Echocardiography protocol for early detection of cardiac dysfunction in childhood cancer survivors in the multicenter DCCSS LATER 2 CARD study: Design, feasibility, and reproducibility.
Merkx R; Leerink JM; Feijen ELAM; Kremer LCM; de Baat EC; Bellersen L; van Dalen EC; van Dulmen-den Broeder E; van der Heiden-van der Loo M; van den Heuvel-Eibrink MM; Korte CL; Loonen J; Louwerens M; Maas AHEM; Pinto YM; Ronckers CM; Teske AJ; Tissing WJE; de Vries ACH; Mavinkurve-Groothuis AMC; van der Pal HJH; Weijers G; Kok WEM; Kapusta L;
Echocardiography; 2021 Jun; 38(6):951-963. PubMed ID: 34013999
[TBL] [Abstract][Full Text] [Related]
13. Atrial Strain Assessment for the Early Detection of Cancer Therapy-Related Cardiac Dysfunction in Breast Cancer Women (The STRANO STUDY: Atrial Strain in Cardio-Oncology).
Di Lisi D; Moreo A; Casavecchia G; Cadeddu Dessalvi C; Bergamini C; Zito C; Madaudo C; Madonna R; Cameli M; Novo G
J Clin Med; 2023 Nov; 12(22):. PubMed ID: 38002739
[TBL] [Abstract][Full Text] [Related]
14. Global and Regional Longitudinal Strain Reduction in Breast Cancer Patients After First Chemotherapy Cycle With Fluorouracil, Adriamycin, and Cyclophosphamide Regimen.
Astuti A; Erwinanto E; Akbar MR; Martanto E; Badudu DF
Cardiol Res; 2021 Aug; 12(4):238-243. PubMed ID: 34349865
[TBL] [Abstract][Full Text] [Related]
15. Left Ventricular Twist and the "Rigid Body Rotation" Pattern in Patients Treated with Anthracyclines or Anti-HER2.
Guerra F; Stronati G; Frangione A; Rrapaj E; Flori M; Alfieri M; Principi S; Barbarossa A; Ciliberti G; Dello Russo A
J Clin Med; 2024 Jun; 13(11):. PubMed ID: 38893063
[No Abstract] [Full Text] [Related]
16. Heart failure related to contemporary breast cancer treatment.
Durkin M; DeJesus N
JAAPA; 2024 Apr; 37(4):29-33. PubMed ID: 38531031
[TBL] [Abstract][Full Text] [Related]
17. Cardiac dysfunction and their determinants in patients treated for breast cancer and lymphoma: A cardio-oncology center experience.
Khaled S; Abdelkhalek S; Aljuwaybiri R; Almatrafi J; AlHarbi A; Almarhabi R; Alyamani F; Soliman M; Jubran E; Shalaby G
Curr Probl Cardiol; 2024 Jan; 49(1 Pt C):102187. PubMed ID: 37913931
[TBL] [Abstract][Full Text] [Related]
18. Serial changes of layer-specific myocardial function according to chemotherapy regimen in patients with breast cancer.
Kim MN; Kim SR; Kim HD; Cho DH; Jung SP; Park KH; Park SM
Eur Heart J Open; 2022 Jul; 2(4):oeac008. PubMed ID: 36117949
[TBL] [Abstract][Full Text] [Related]
19. Echocardiographic Assessment of Left Ventricular Function in Three Oncologic Therapeutic Modalities in Women with Breast Cancer: The ONCO-ECHO Multicenter Study.
Gąsior T; Zaborska B; Stachowiak P; Sikora-Frąc M; Mizia-Stec K; Kasprzak J; Bodys A; Bijoch J; Szmagała A; Kosior DA; Płońska-Gościniak E
J Clin Med; 2024 Apr; 13(9):. PubMed ID: 38731072
[No Abstract] [Full Text] [Related]
20. Heart rate variability-based prediction of early cardiotoxicity in breast-cancer patients treated with anthracyclines and trastuzumab.
Luna-Alcala S; Espejel-Guzmán A; Lerma C; Leon P; Guerra EC; Fernández JRE; Martinez-Dominguez P; Serrano-Roman J; Cabello-Ganem A; Aparicio-Ortiz AD; Keirns C; Lerma A; Ana-Bayona MJS; Espinola-Zavaleta N
Cardiooncology; 2024 May; 10(1):32. PubMed ID: 38812020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
